Bell Investment Advisors’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-255
Closed -$4.26K 2016
2022
Q4
$4.26K Sell
255
-29
-10% -$490 ﹤0.01% 892
2022
Q3
$5K Buy
284
+88
+45% +$1.38K ﹤0.01% 736
2022
Q2
$2K Buy
+196
New +$1.68K ﹤0.01% 1284
2021
Q4
$1K Sell
33
-10
-23% -$194 ﹤0.01% 1715
2021
Q3
$1K Buy
+43
New +$1.1K ﹤0.01% 1669

Bell Investment Advisors's ONEM Position: Q1 2023 in Review

Bell Investment Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 255 shares — an estimated $4.26K sold.

Bell Investment Advisors first reported a position in ONEM in Q3 2021 and held it in 5 quarters. The position peaked at $5K in Q3 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Bell Investment Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Bell Investment Advisors sold 255 1Life Healthcare shares in Q1 2023, an estimated $4.26K.
  • Bell Investment Advisors first reported a position in 1Life Healthcare in Q3 2021 and held it in 5 quarters.
  • Bell Investment Advisors's 1Life Healthcare position peaked at $5K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Bell Investment Advisors's 13F filing for Q1 2023, filed 10 May 2023.